Oct 03 Love0 A New Oral Rosacea Treatment Enters Testing: Remibrutinib’s 2026–2027 Trial By Pedro Oliva Jr. Skin Health A newly recruiting clinical trial is testing whether an oral immune-signaling medicine can reduce inflammatory facial lesions in a specific form of rosacea. For people in Fort Myers who deal with persistent bumps…Read More